Tulane University and 60 Degrees Entered into a Research Agreement Announcement Leading pharmaceutical company, 60 degrees pharmaceuticals, known for its sharp focus on the development of new medicines for infectious diseases, has signed a research agreement with Tulane University to monitor the...
Sarepta's Strategic Plans and Upgradation in the ELEVIDYS Label Sarepta Therapeutics Inc., after achieving major milestones in the precision genetic medicine for rare diseases, is now planning to elevate its business by reshaping its strategic plans that will be fueling programs to achieve 2027...
Nature Medicine’s Results are Out Announcement Innovent Biologics, Inc., a biopharmaceutical company that manufactures, commercializes, and develops medicines for the treatment of oncology, metabolic, ophthalmology, autoimmune, cardiovascular, and other severe diseases, confirmed that th...
Amphix Bio's New Milestone in the Treatment of Acute Spinal Cord Injury Amphix Bio, a pre-clinical company that is building a new therapeutic modality for regenerative medicine, has received orphan drug designation for AMFX-200, a treatment for acute spinal cord injury (SCI). SCI is an extreme ...
ASAP and the Allen Institute Gathered to Discover Insights into Parkinson's and Other Diseases Announcement The Allen Institute and the Aligning Science Across Parkinson’s 9asap initiative are gathering to explore insights into neurodegenerative-related disease and Parkinson's with its...
MilliporeSigma’s AAW™ Workstation Announcement The Canadian and US life science business, MilliporeSigma of Darmstadt, Merck KGaA, and Germany, as a global science and technology company, has introduced the AAW automated assay workstation. It is a solution for Opentrons. Opentrons ...
Lily’s New Formulation for Active CD Received Approval Announcement Eli Lily Canada Inc. received approval from Health Canada for Omvoh® (mirikizumab) for CD. It will be available soon for Canadian patients. This drug is an interleukin-23p19 antagonist used for the treatment of adult...
Time to Appreciate Women-led Biotech: Know More About the Leaders in Biotech Industry Accomplishment Last year's record shows that most of the standard acquisitions consist of women-led biotech valuable contributions to the biotech’s growth. The biopharma is strengthened and positioned h...
Akeso Enrolled First Patient for MCRc Akeso Inc. has enrolled its first patient in the registration phase 3 clinical trial AK112-312/HARMONi-GI6 of ivonescimab for its primary treatment of advanced metastatic colorectal cancer (mCRC). The phase 3 trial is a center for the company to achieve pri...
Kraig’s New Addition to the Healthcare Market Announcement Kraig Biocraft Laboratories Inc., a global leader in spider silk technology, has initiated a second parallel production facility, the quick introduction of a new diapausing system, and three new advanced spider silk strains for p...
